Evidence map›Paper›PMID 34676773›Full record

ArticleJournal of comparative effectiveness research2021

Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data.

Imi Faghmous, Francis Nissen, Peter Kuebler, Carlos Flores, Anisha M Patel, Steven W Pipe

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Journal of comparative effectiveness research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Hemophilia patients: are they naturally anticoagulated?Internal and emergency medicine · 2023
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Imi FaghmousReal-World Data Oncology-Hematology, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, 4070, Switzerland.
Francis NissenReal-World Data Oncology-Hematology, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, 4070, Switzerland.ORCID 0000-0002-8747-0982
Peter KueblerPHC Safety Interface, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Carlos FloresEvidence Strategy, Genesis Research Hoboken, 111 River St Ste 1120, Hoboken, NJ 07030, USA.ORCID 0000-0002-0574-4258
Anisha M PatelUS Medical Affairs, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.ORCID 0000-0003-1902-905X
Steven W PipePediatrics and Pathology, University of Michigan, D4202 MPB, 1500 E Medical Center Drive, Ann Arbor, MI 48109-5718, USA.ORCID 0000-0003-2558-2089
Roche (Switzerland) · CHInterface (United States) · USUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hemophilia AMyocardial InfarctionPulmonary EmbolismStrokeThrombosisHumansRisk Factorshemophilia Ahemostasisischemic strokemyocardial infarctionpulmonary embolismtherapeuticsthrombosisvascular access devicesvenous thrombosis

Identifiers

PMID34676773
OpenAlexW3205432769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.